FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)
CUSIP: 31447P100
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 34,763,175
- Total 13F shares
- 11,367,575
- Share change
- +93,803
- Total reported value
- $92,077,143
- Put/Call ratio
- 136%
- Price per share
- $8.10
- Number of holders
- 29
- Value change
- +$913,826
- Number of buys
- 10
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 31447P100?
CUSIP 31447P100 identifies FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31447P100:
Top shareholders of FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Southpoint Capital Advisors LP |
13F
|
Company |
12%
|
4,077,214
|
$22,751,000 | — | 30 Jun 2022 | |
| Sonic Fund II, L.P. |
13F
|
Company |
6.9%
|
2,407,357
|
$13,433,000 | — | 30 Jun 2022 | |
| DG Capital Management, LLC |
13F
|
Company |
3.5%
|
1,210,638
|
$6,840,000 | — | 30 Jun 2022 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
3.5%
|
1,200,000
|
$6,780,000 | — | 30 Jun 2022 | |
| Solas Capital Management, LLC |
13F
|
Company |
3.4%
|
1,173,516
|
$6,548,000 | — | 30 Jun 2022 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.2%
|
425,338
|
$2,373,000 | — | 30 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.68%
|
237,392
|
$1,341,000 | — | 30 Jun 2022 | |
| HARBERT FUND ADVISORS, INC. |
13F
|
Company |
0.55%
|
189,750
|
$1,059,000 | — | 30 Jun 2022 | |
| Tamar Securities, LLC |
13F
|
Company |
0.15%
|
53,475
|
$302,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.15%
|
51,369
|
$287,000 | — | 30 Jun 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.14%
|
49,075
|
$277,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.12%
|
40,335
|
$225,000 | — | 30 Jun 2022 | |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV |
13F
|
Company |
0.12%
|
40,000
|
$223,000 | — | 30 Jun 2022 | |
| Hartford Financial Management Inc. |
13F
|
Company |
0.1%
|
34,848
|
$197,000 | — | 30 Jun 2022 | |
| Wealthspire Advisors, LLC |
13F
|
Company |
0.07%
|
25,000
|
$141,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
19,507
|
$110,000 | — | 30 Jun 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
7,735
|
$69,000 | — | 30 Jun 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.03%
|
11,220
|
$63,000 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
10,029
|
$56,000 | — | 30 Jun 2022 | |
| Ancora Advisors LLC |
13F
|
Company |
0.02%
|
6,000
|
$33,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
4,961
|
$28,000 | — | 30 Jun 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,977
|
$23,000 | — | 30 Jun 2022 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
2,177
|
$12,000 | — | 30 Jun 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
273
|
$2,000 | — | 30 Jun 2022 | |
| FMR LLC |
13F
|
Company |
0%
|
112
|
$1,000 | — | 30 Jun 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
170
|
$949 | — | 30 Jun 2022 | |
| Shubh Goel |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
112,500
mixed-class rows
|
— | — | 20 Dec 2021 |
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q3 2022
As of 30 Sep 2022,
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,367,575 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, Sonic Fund II, L.P., Avoro Capital Advisors LLC, Solas Capital Management, LLC, DG Capital Management, LLC, 683 Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, HARBERT FUND ADVISORS, INC., EAM Investors, LLC, and Tamarack Advisers, LP.
This page lists
29
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
24
Q3 2022 holders
29
Holder diff
5
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.